News
Enavate Sciences joins Cormorant Asset Management, Pontifax Venture Capital and Ovid Therapeutics in supporting Graviton's development of ROCK2 inhibitors across multiple indications NEW YORK ...
MENLO PARK, Calif., Jan. 16, 2024 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Christine Del Corsano has joined the firm as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
